Clinical Trial Update: The Study of Abatacept in Combination With Etanercept [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating the combination of abatacept and etanercept in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED